Pharmacology for Nurses · Reproductive Health Drugs
Androgens, Antiandrogens, and Anabolic Steroids
On this page 9 sections
In 30 seconds
This topic applies the physiology of the male reproductive system (Topic 5) to pharmacology. Androgens are the male sex hormones — testosterone and its synthetic relatives — used therapeutically when the body's own supply is inadequate. Anabolic steroids are Androgen Steroid hormone with masculinizing effects (e.g., testosterone) Full entry → derivatives engineered to emphasize tissue-building (anabolic) effects; they have legitimate uses but are also misused for performance enhancement. Antiandrogens do the opposite job: they block androgen production or androgen action, and they are central to treating prostate cancer and a few other conditions. Understanding all three in one frame makes the pattern clear: hormones, their tissue-building relatives, and the drugs that shut them down.
Because androgens are controlled substances with real abuse potential, and because Antiandrogen Drug that blocks androgen production or androgen action Full entry → therapy changes how a person feels, looks, and functions, this is a topic where pharmacology knowledge, patient teaching, and respectful communication meet.
Why this matters
- Legitimate therapy with serious side effects. Androgen replacement for Hypogonadism Inadequate endogenous testosterone production Full entry → is common, but it can worsen sleep apnea, raise red blood cell counts, and affect the prostate — nurses monitor these effects.
- Transdermal transfer is a safety issue. Testosterone gels can transfer to other people through skin contact, including women and children. Teaching proper handling is a genuine harm-prevention nursing task.
- Prostate cancer therapy is androgen biology. Androgen deprivation therapy is a mainstay of prostate cancer treatment, and its side effects (hot flashes, fatigue, bone loss) are exactly the topics the nurse teaches and manages.
- Substance misuse is a public health problem. Anabolic steroid Synthetic androgen emphasizing tissue-building effects Full entry → misuse carries cardiovascular, hepatic, and psychiatric risks; nurses may be the first nonjudgmental professional a person talks to.
- Exam relevance: mechanisms (GnRH axis, receptor blockade, enzyme inhibition), the "flare" phenomenon, and adverse-effect profiles are classic test material.
The college version
Core Concepts
Androgen receptors and effects
Androgens are steroid hormones that bind the Androgen receptor Nuclear receptor that androgens activate to change gene expression Full entry →, a nuclear receptor that regulates gene transcription and protein synthesis. The effects ripple across the body: sexual development and libido, spermatogenesis, muscle and bone mass, red blood cell production, hair growth, and mood. Two metabolites complicate the picture: DHT (from 5-alpha-reductase) drives prostate growth and scalp/body hair patterns, and estradiol (from aromatase) can produce breast tissue growth when androgen levels are high. Side effects are therefore often effects of the metabolites, not of testosterone itself.
Therapeutic androgens: uses and delivery
Testosterone and related androgens are used for hypogonadism (inadequate endogenous testosterone), delayed puberty in boys, and some wasting or anemic states under specific indications. Delivery routes include intramuscular injections, transdermal patches and gels, buccal systems, and subcutaneous pellets — each with different handling requirements. The gel route has a distinctive nursing teaching point: the drug stays on the skin, so hands must be washed after application, application sites should be covered, and skin-to-skin contact with others should be avoided. Any androgen therapy is a prescriber decision with monitoring (blood counts, lipids, prostate-specific antigen) — no doses are given here; verify everything against current references.
Adverse effects of androgen therapy
Therapeutic androgens can cause Virilization Development of male secondary characteristics in a female Full entry → (in females), acne, gynecomastia (Aromatization Conversion of testosterone to estradiol by aromatase Full entry → to estradiol), fluid retention, unfavorable lipid changes, erythrocytosis (rising red blood cell counts that can thicken the blood), sleep apnea, and prostate growth with rising PSA. Long-term use suppresses the HPG axis, so fertility and testicular size may be affected (see Topic 5). Monitoring is typically driven by the indication and the prescriber's plan — the nurse's job is to know which effects to watch for, ask about, and document.
Anabolic steroids: pharmacology and misuse
Anabolic steroids are synthetic androgens designed to maximize anabolic (building) effects relative to androgenic (masculinizing) effects — but they are still androgens, and they still activate androgen receptors. Misuse is associated with cardiovascular problems (blood pressure, lipid changes, and effects on the heart), liver injury with some oral forms, psychiatric effects, suppression of the HPG axis (which can leave a person with low endogenous testosterone and infertility after stopping), virilization in females, and premature growth-plate closure in adolescents. These agents are controlled substances; possession and use outside legitimate medical channels are regulated. Persons using them need nonjudgmental, evidence-based discussion of the risks — and referral for legitimate evaluation when appropriate.
Antiandrogens: cutting production
Prostate cancer is androgen-sensitive — it grows when androgen signals drive it. One strategy is to cut testosterone production itself:
- GnRH agonists (class examples: leuprolide, goserelin) overstimulate the pituitary, which paradoxically suppresses LH release after an initial stimulation — testosterone falls to castrate levels. The brief initial rise in testosterone is the Flare phenomenon Brief rise in testosterone before GnRH-agonist suppression takes effect Full entry →, a recognized class effect that prescribers manage according to current practice.
- GnRH antagonists suppress LH more rapidly, without the flare.
- CYP17 inhibitors (class example: abiraterone) block an enzyme needed for androgen synthesis in the testes, adrenals, and prostate tumor tissue; they are used in advanced disease with other agents per current regimens.
Antiandrogens: blocking the receptor
The second strategy is to block androgen signaling at the receptor. Androgen receptor antagonists (class examples: flutamide, bicalutamide, enzalutamide) occupy the androgen receptor so DHT and testosterone cannot activate it. They are used mainly in prostate cancer. 5-alpha-reductase inhibitors (finasteride, dutasteride) take a different route — they reduce DHT formation — and are covered in detail in Topic 8. Common effects of androgen blockade include hot flashes, gynecomastia, decreased libido, fatigue, and, with long-term use, bone loss — which is why calcium, vitamin D, and bone health (Topic 4) become nursing priorities in this population.
Nursing considerations
Androgen and antiandrogen therapy demand more than drug knowledge. The nurse verifies the order and the product, teaches transdermal handling and fertility implications, monitors the effects that matter for the specific therapy (blood counts, lipids, PSA, mood, bone health), and communicates about sexual function and body changes with person-first language and without judgment. Scope varies by state and institution — assessment, administration, teaching, and monitoring are nursing acts; prescribing and therapy selection are not.
Common Confusions
| Do not confuse | With | Difference |
|---|---|---|
| GnRH agonist | GnRH antagonist | Agonist suppresses after an initial flare; antagonist suppresses rapidly without flare |
| Testosterone therapy | Anabolic steroid misuse | Both are androgens, but therapy is monitored and prescribed; misuse is unregulated and carries added risks |
| Antiandrogen | Androgen | Antiandrogens block production or action; androgens activate the receptor |
| Gynecomastia from androgens | "Too much testosterone directly" | It is largely an effect of estradiol formed by aromatization of testosterone |
| Androgen deprivation therapy | A cure for prostate cancer | It suppresses androgen signaling to control the cancer; it is not curative in most settings |
| 5-alpha-reductase inhibitors | Androgen receptor antagonists | 5-ARIs lower DHT formation; receptor antagonists block DHT/testosterone at the receptor |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Testosterone is like a key that fits special locks on cells, telling the body to build muscle, grow hair, and make sperm. Androgens are keys like that. Antiandrogens are like putting glue on the keyhole or taking the key factory out of business — the lock can't open, so the body gets the message "no building." That is useful in prostate cancer, because the cancer grows when those locks open. Anabolic steroids are super-strong copies of the key that people sometimes take to build muscle fast — but they make the brain turn down its own key-making, and they can hurt the heart and liver.
Worked example
Mr. D., age 71, has prostate cancer, and his prescriber is starting a GnRH agonist. The nurse's teaching covers the whole picture:
- Why this drug? Prostate cancer cells grow when androgen signals activate them. The GnRH agonist will eventually drop Mr. D.'s testosterone to very low ("castrate") levels, starving the cancer of its growth signal.
- What to expect early. The nurse explains that testosterone may briefly rise before it falls (the flare), so short-term effects can differ from long-term ones; the prescriber's plan for the early phase is followed exactly as ordered.
- Living with low testosterone. Hot flashes, fatigue, decreased libido, and possible breast tenderness are common; the nurse normalizes them, suggests practical coping strategies, and reminds Mr. D. about calcium, vitamin D, and bone health follow-up, since long-term androgen deprivation weakens bone (Topic 4).
- Monitoring. PSA, blood counts, bone density, and symptom review follow the prescriber's plan; the nurse documents what Mr. D. reports and flags changes.
Separately, a younger patient may ask about testosterone gel they obtained from a friend. The nurse explains the transfer risk to anyone who touches the application site, the HPG-suppression and fertility effects, and the reasons to seek legitimate evaluation — without judgment.
Safety note: This scenario illustrates mechanisms and teaching themes only. Actual agents, regimens, flare management, and monitoring are prescriber decisions that vary by disease state, product, and institution — always verify against current references, the facility formulary, and the prescriber's orders.
Key takeaways
- Androgens act through the androgen receptor — a nuclear receptor that changes gene transcription; effects are systemic (muscle, bone, blood, libido, hair).
- Metabolites explain side effects: DHT (5-alpha-reductase) drives prostate growth; estradiol (aromatase) can cause gynecomastia.
- Androgen therapy suppresses the HPG axis — fertility and testicular size can be affected (link to Topic 5).
- Transdermal gels transfer by skin contact — hand washing, covering sites, and avoiding skin-to-skin contact are critical teaching points.
- Anabolic steroids are still androgens — misuse carries cardiovascular, hepatic, psychiatric, and HPG-suppression risks; they are controlled substances.
- GnRH agonists suppress testosterone after an initial flare; GnRH antagonists avoid the flare.
- Androgen receptor antagonists block the receptor; 5-alpha-reductase inhibitors lower DHT (Topic 8).
- Androgen deprivation causes hot flashes, gynecomastia, fatigue, and long-term bone loss — bone health (Topic 4) becomes a nursing priority.
- No doses, schedules, or regimens here: all therapy decisions belong to the prescriber — verify against current references, the formulary, and prescriber orders.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
What is the molecular target shared by androgens and androgen receptor antagonists?
Show answer
The androgen receptor — a nuclear receptor that regulates gene transcription. Androgens activate it; receptor antagonists occupy it and block activation.
Why does exogenous testosterone reduce sperm count and testicular size?
Show answer
Exogenous testosterone raises blood androgen levels, and negative feedback suppresses GnRH and LH (and FSH), so the testes reduce their own testosterone production and spermatogenesis (see Topic 5).
What is the flare phenomenon, and with which drug class does it occur?
Show answer
A brief rise in testosterone before suppression takes effect, seen with GnRH agonists (the initial overstimulation precedes pituitary suppression).
Why can high androgen levels cause gynecomastia?
Show answer
Aromatase converts some testosterone to estradiol, and estradiol stimulates breast tissue — so androgen excess can present as gynecomastia.
What is the key safety teaching point for transdermal testosterone gels?
Show answer
The drug remains on the skin: wash hands after application, cover application sites, and avoid skin-to-skin contact with others (especially women and children).
Why does long-term androgen deprivation therapy raise the importance of bone health?
Show answer
Androgen deprivation removes the bone-protective effects of testosterone, accelerating bone loss — so calcium, vitamin D, and bone density monitoring become priorities (Topic 4).
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Androgen
- Steroid hormone with masculinizing effects (e.g., testosterone)
- Androgen receptor
- Nuclear receptor that androgens activate to change gene expression
- Hypogonadism
- Inadequate endogenous testosterone production
- Anabolic steroid
- Synthetic androgen emphasizing tissue-building effects
- GnRH agonist
- Drug that overstimulates then suppresses the pituitary, dropping testosterone
- Flare phenomenon
- Brief rise in testosterone before GnRH-agonist suppression takes effect
- Antiandrogen
- Drug that blocks androgen production or androgen action
- Virilization
- Development of male secondary characteristics in a female
- Aromatization
- Conversion of testosterone to estradiol by aromatase
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.